Clinical Trial: Oral Sucrosomial(R) Vitamin B12 in the Management of B12 Deficiency Among Metformin-Treated Type 2 Diabetes Patients

U.S., May 22 -- ClinicalTrials.gov registry received information related to the study (NCT06983223) titled 'Oral Sucrosomial(R) Vitamin B12 in the Management of B12 Deficiency Among Metformin-Treated Type 2 Diabetes Patients' on May 12.

Brief Summary: This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the effectiveness of Sucrosomial(R) Vitamin B12 supplementation in the management of vitamin B12 deficiency among metformin-treated Type 2 Diabetes Mellitus (T2DM) patients. The study will compare the impact of daily Sucrosomial(R) B12 (1,000 mcg) versus placebo on serum vitamin B12 levels, Holo-Transcobalamin II (HoloTCII), and Transcobalamin I (TCI) levels over a 4-week period. Secondary outcomes include asses...